Back to Cryopyrin-Associated Periodic Syndrome

Cryopyrin-Associated Periodic Syndrome — Clinical Trials

MONDO:00161683 active·3 recruitingLast updated: Mar 16, 2026, 7:19 PM

Trial Landscape

Cryopyrin-Associated Periodic Syndrome has an emerging clinical trial program, driven by drug treatment and biological therapy.

Recruiting

Active Trials

By Approach

Drug Treatment2

Biological Therapy1

By Phase

Phase 1

1 trials are observational or have no phase designation.

Sponsor Types

Industry2NIH1

Top Sponsors

Akros Pharma Inc.

Novartis Pharmaceuticals

Trial Locations

South Korea1 trial

Canada1 trial

United States1 trial

Trials often recruit across multiple countries, so totals exceed the trial count.

2 of 3 Trials

Phase 1Recruiting

NCT06974877

Repeat PET/CT Imaging in People With CAPS and Anakinra-Induced Amyloidosis Using an Amyloid-Reactive Peptide to Measure Changes in Organ-Specific Amyloid Load

Sponsor:National Institute of Allergy and Infectious Diseases (NIAID)

United StatesStarted: Sep 2025Est. completion: Jan 2032Updated: Feb 2026

Phase 1Recruiting

NCT07247266

Study to Evaluate the Safety, Tolerability, Efficacy and Pharmacokinetics of JTE-162 in Subjects With Cryopyrin-Associated Periodic Syndrome (CAPS)

Sponsor:Akros Pharma Inc.

CanadaStarted: Feb 2026Est. completion: Dec 2026Updated: Feb 2026

Stay informed about clinical trials for Cryopyrin-Associated Periodic Syndrome.

Follow this disease to get updates when trials open, close, or change status.

Follow This Disease — Free

Already have an account? Sign in to manage your watchlists.

Data sourced from ClinicalTrials.gov via Kisho's automated pipeline. Trials refreshed every 4 hours for monitored diseases.

Last sync: March 16, 2026 at 7:19 PM